300239 深市 东宝生物

                2022 年度财务决算报告

      包头东宝生物技术股份有限公司2022年度财务报表已经信永中和会计师事务所(特殊普通合
 伙)审计，并出具了标准无保留意见审计报告。会计师的审计意见为：东宝生物的财务报表在所 有重大方面按照企业会计准则的规定编制，公允反映了东宝生物2022年12月31日的合并及母公司 财务状况以及2022年度的合并及母公司经营成果和现金流量。

      现将2022年度财务决算情况汇报如下：

    一、主要会计数据和财务指标

          项  目                  2022 年          2021 年          本年比上年增减  2020 年

营业收入（元）                    943,396,998.69    612,165,671.91    54.11%          448,827,791.89

归属于上市公司股东的净利润（元）  109,437,321.14    36,484,130.69      199.96%          18,450,301.36

归属于上市公司股东的扣除非经常性  100,942,931.19    26,920,029.36      274.97%          11,857,395.88

损益的净利润（元）

经营活动产生的现金流量净额（元）  195,317,536.56    51,501,086.21      279.25%          63,129,603.25

基本每股收益（元/股）              0.1844            0.0647            185.01%          0.0353

稀释每股收益（元/股）              0.1844            0.0647            185.01%          0.0353

加权平均净资产收益率              7.42%            2.94%            4.48%            1.86%

          项  目                2022 年末        2021 年末        本年末比上年末  2020 年末

                                                                    增减

资产总额（元）                    2,308,113,622.60    2,112,240,503.24    9.27%            1,417,934,200.36

归属于上市公司股东的净资产（元）  1,528,509,817.66  1,422,692,834.57  7.44%            989,956,482.67

    二、财务状况、经营成果、现金流量分析

    （一）财务状况分析

      1、资产项目重大变动情况

                                                                                金额单位：人民币元

            项  目                  期末余额        期初余额        变动金额        变动幅度

流动资产：

    货币资金                        356,112,280.55    225,870,281.01    130,241,999.54          57.66%

    应收票据                        123,041,604.09    100,662,045.64      22,379,558.45          22.23%

    应收账款                        146,117,208.28    150,447,709.39      -4,330,501.11          -2.88%

    应收款项融资                      66,626,977.57      51,355,599. 71      15,271,377.86          29.74%

    预付款项                          10,500,393.81      11,477,263. 56        -976,869.75          -8.51%

    其他应收款                        3,148,380.54      5,191,422.21      -2,043,041.67          -39.35%

    存货                            317,835,953.32    346,024,944.96    -28,188,991.64          -8.15%

    其他流动资产                        507,993.64      1,563,632.90      -1,055,639.26          -67.51%

流动资产合计                        1,023,890,791.80    892,592,899.38    131,297,892.42          14.71%

非流动资产：

    长期股权投资                      22,694,547.96      29,260,756. 96      -6,566,209.00          -22.44%

    其他权益工具投资                  5,621,494.45      5,621,494.45            0.00            0.00

    投资性房地产                      36,441,434.44      15,942,184. 22      20,499,250.22          128.58%

    固定资产                        858,791,445.24    872,804,862.36    -14,013,417.12          -1.61%

    在建工程                        160,292,267.28      94,095,899. 90      66,196,367.38          70.35%

    无形资产                        152,135,368.74    174,599,722.07    -22,464,353.33          -12.87%

    开发支出                          2,035,433.96      7,737,038.35      -5,701,604.39          -73.69%

    长期待摊费用                      2,598,730.70        1,724,515.3        874,215.40          50.69%

    递延所得税资产                    11,844,768.92      10,673,084. 55      1,171,684.37          10.98%

    其他非流动资产                    31,767,339.11      7,188,045.70      24,579,293.41          341.95%

非流动资产合计                      1,284,222,830.80  1,219,647,603.86      64,575,226.94            5.29%

资产总计                            2,308,113,622.60    2,112,240,503.24    195,873,119.36            9.27%

  （1）期末货币资金大幅增长主要是本期收入增加收到的现金增加，以及取得的银行借款增加 所致。

  （2）期末应收款项融资增加主要是持有的银行承兑汇票增加所致。

  （3）期末其他应收账款减少主要是报告期内收回往来款所致。

  （4）期末其他流动资产减少主要是增值税留抵税减少所致。

  （5）期末投资性房地产大幅增长主要是报告期内对外出租土地使用权，自无形资产转入所致。
  （6）期末在建工程大幅增长主要是报告期内新型空心胶囊智能产业化项目以及废水资源综合 利用项目投入增加所致。

  （7）期末开发支出减少主要是研发项目结题验收所致。

  （8）期末长期待摊费用增加主要是报告期内发生的改建修缮支出增加所致。

  （9）期末其他非流动资产大幅增长主要是预付的设备、工程款增加所致。

      2、负债项目重大变动情况

                                                                                金额单位：人民币元

            项  目                  期末余额        期初余额        变动金额        变动幅度

流动负债：

    短期借款                          2,070,699.94      50,516,283. 81    -48,445,583.87          -95.90%

    应付票据                          29,604,980.50      50,140,000. 00    -20,535,019.50          -40.96%

    应付账款                          95,180,644.17      91,446,439. 27      3,734,204.90            4.08%

    合同负债                          14,285,932.23      4,796,704.41      9,489,227.82          197.83%

    应付职工薪酬                      9,190,939.92      6,408,165.26      2,782,774.66          43.43%

    应交税费                          15,011,818.94      13,232,753. 26      1,779,065.68          13.44%

    其他应付款                        13,657,212.61    134,162,099.09    -120,504,886.48          -89.82%

    一年内到期的非流动负债            41,016,910.43                      41,016,910.43

    其他流动